Spain · AEMPS CIMA

vacuna anti COVID-19 (Novavax) proteína recombinante de la espícula de SARS-COV-2

Source ingredient · 1 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.